NetScientific PLC Preliminary Results for the year ended 31 December 2021

Good results demonstrate excellent progress in growth strategy to realise shareholder returns

NetScientific plc (AIM: NSCI), the international life sciences and sustainability, technology investment and commercialisation group, announces its preliminary results for the year ended 31 December 2021.

This was an excellent year of progress for the company as shown in the results. Implementation of its planned growth strategy  has accelerated and delivered a step change, both strategically and tactically.

NetScientific plc (AIM: NSCI), the international life sciences and sustainability, technology investment and commercialisation group, announces its preliminary results for the year ended 31 December 2021.

This was an excellent year of progress for the company as shown in the results. Implementation of its planned growth strategy  has accelerated and delivered a step change, both strategically and tactically.

Highlights:

· Practical completion of the business turnaround

· Proactive management focused on delivering significant returns

· Raised £7.7 million in an oversubscribed placing 

o  Enabled acceleration of investment and growth

· Further expansion of the well-balanced portfolio from 17 to 22 companies in targeted sectors

o  Deeper involvement in selected companies, potential for greater returns;

o  Judicious investments, combining direct balance sheet with “capital light” approach

o  Direct investments of c.£4.5m in 9 portfolio companies, plus Cetromed acquisition and new stake in Martlet Capital - supplemented with syndicated investments adding £7.5m to “capital under advisory”

o  Key value inflection points identified for profitable liquidity events and exits

· Loss for the year of £2.9m (2020: loss £2.3m) reflecting substantial expensed R&D investment and continued building of the NetScientific platform

· Transformed financial position

o  Increases of around 50% in “fair value” and “capital under advisory”

o  Strengthened balance sheet, 69% increase in cash to £2.7 million (2020: £1.6 million)

o  156% increase in total assets £20.7 million (2020: £8.1 million)

· Progress in “Trans-Atlantic bridges” programme and international expansion

· Strong position, well placed to realise optimal shareholder value

Post Period Highlights:

· Acquisition of 30% of Vortex Biotech Holdings

Analyst Briefing: 09.30, Thursday 12 May

Management will be hosting a remote presentation via web conference today at 09.30 BST. Analysts wishing to join should register their interest by emailing netscientific@walbrookpr.com or by telephoning 020 7933 8780.

Investor Presentation: 16.00, Thursday 12 May

The Company will be hosting a presentation to discuss the results through the digital platform, Investor Meet Company, at 16.00 today.

Investors can sign up to Investor Meet Company for free and add to meet NetScientific via the following link https://www.investormeetcompany.com/netscientific-plc/register-investor

Dr. Ilian Iliev, CEO and John Clarkson, Executive Chairman of NetScientific commented: “We are delighted with the Company’s performance during the period. The business has been transformed and we have a clear, planned route and growth strategy to optimise shareholder value from our investments.”

“We remain extremely excited by the growth trajectory of our current portfolio and look forward to adding to this further in due course. This will be supplemented by the creation of a hub in America, which we believe will further enable us to drive value, with our focus on identifying liquidity events and exits at the appropriate juncture.”

For more information, please contact:

About NetScientific

NetScientific plc (AIM: NSCI) is a holding company, that invests in, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies, which offer significant growth potential predominately in the UK,  USA, EU and beyond. 

The Group has nearly trebled its portfolio from 8 to 22 companies, either through subsidiary, direct balance sheet investment or capital under advisory, varying from start-up private companies to publicly listed equities. 

NetScientific delivers shareholder returns through a proactive and hands-on management approach to their portfolio companies; identifying, investing in, and helping to build game-changing companies. The Group targets value inflection points and the release of value through partial or full exits from trade sales, public listings, or equity sales. The Company has a strong transatlantic and growing international presence, providing attractive expansion prospects. 

NSCI can deploy a capital-light investment structure; utilising the power of the PLC Brand, and the NetScientific balance sheet to anchor future investments and achieve a multiplier effect by attracting 3rd party investment for the portfolio companies. 

NetScientific is headquartered in London, United Kingdom, and was admitted to trading on AIM, a market operated by the London Stock Exchange, in 2013 (website: netscientific.net).